Tg Therapeutics TGTX
NASDAQ TGTX
$53.16 -0.04 (-0.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tg Therapeutics (TGTX) Accumulated Expenses (2010 - 2013)

Updated

Analysis

Tg Therapeutics (TGTX) Accumulated Expenses (2010 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Tg Therapeutics 8.14 Bn 7.53 Bn 199.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 190,017.00
Sep 30, 2013 172,751.00
Jun 30, 2013 155,829.00
Mar 31, 2013 139,421.00
Dec 31, 2012 123,511.00
Sep 30, 2012 107,569.00
Jun 30, 2012 91,944.00
Mar 31, 2012 76,793.00
Dec 31, 2011 61,941.00
Sep 30, 2011 47,223.00
Jun 30, 2011 160,061.00
Dec 31, 2010 480,890.00
API Access

Tg Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TGTX&period=max&api_key=YOUR_API_KEY